Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Eltrombopag olamine

Eltrombopag olamine

pharmaceutical raw materials
Eltrombopag olamine structure

Eltrombopag olamine 

structure
  • CAS No:

    496775-62-3

  • Formula:

    C25H22N4O4.2C2H7NO

  • Chemical Name:

    Eltrombopag olamine

  • Synonyms:

    [1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);SB 497115GR;Eltrombopag olamine;Promacta;Eltrombopag diethanolamine salt;Revolade

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Eltrombopag is a thrombopoietin-receptor agonist used to treat low blood platelet counts with chronic immune thrombocytopenia.


Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO-R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO-R leads to the proliferation and differentiation of cells in the megakaryocytic lineage and an increase in platelet production.

Eltrombopag olamine Basic Attributes

564.63

564.269653

1308068-626-2

4U07F515LG

C62501

B02BX05

Characteristics

207

3.12780

Safety Information

|Danger|H302 (16.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P260, P264, P270, P273, P280, P301+P312, P305+P351+P338, P310, P314, P330, P337+P313, P391, and P501|Aggregated GHS information provided by 6 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Revolade is indicated for chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients aged 1 year and above who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).Revolade is indicated in adult patients with chronic hepatitis C virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy.Revolade is indicated in adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation.|Drug: Eltrombopagolamine

eltrombopag

Eltrombopag olamine Use and Manufacturing

Uses

Treatment of chemotherapy-induced thrombocytopenia and treatment of immune thrombocytopenic purpura.

Human drugs -> Revolade -> EMA Drug Category|Other systemic hemostatics, Antihemorrhagics -> Human pharmacotherapeutic group|Human drugs -> Rare disease (orphan)|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:564.6
Hydrogen Bond Donor Count:7
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:7
Exact Mass:564.26963289
Monoisotopic Mass:564.26963289
Topological Polar Surface Area:207
Heavy Atom Count:41
Complexity:822
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist that interacts with the transmembrane domain of the human TPO receptor, initiates a signaling cascade, and induces proliferation and differentiation of bone marrow progenitor cells. Due to the unique specificity of the TPO receptor, eltrombopag does not stimulate platelet production in rats, mice, or dogs.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • OPTIMUS DRUGS PRIVATE LTD

    United States United States
    Active
  • BIOPHORE INDIA PHARMACEUTICALS PVT LTD

    United States United States
    Active
  • SHILPA PHARMA LIFESCIENCES LTD

    United States United States
    Active

Recommended Suppliers of Eltrombopag olamine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.